Broadening Our Understanding of Early Versus Late Influenza Vaccine Effectiveness
BELIEVE
3 other identifiers
observational
470
1 country
1
Brief Summary
This study uses a prospective cohort design to investigate if the seasonal influenza vaccine is equally effective when given early and late before the proceeding influenza season. All health care workers will be vaccinated for seasonal influenza either 3 months before or 1 month prior to the start of the influenza season. HCWs that consent to take part in the study will have 4 blood samples taken for an antibody check. The initial antibody checks will be done just prior to vaccination as well as 2 weeks after vaccination. Subsequent samples will be taken at the peak of influenza season and at the end of the influenza season. HCWs that develop ILI during the course of the influenza season will be asked to complete a questionnaire and oropharyngeal self-swab. HCWs will also provide exhaled breath samples and wear a mask in order to evaluate novel non-invasive methods for diagnosis of influenza. Influenza positive and negative inpatients identified through the University of Leicester's laboratory system will also be asked to provide breath samples to evaluate this technique for the diagnosis of influenza.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 24, 2020
CompletedStudy Start
First participant enrolled
September 28, 2020
CompletedFirst Posted
Study publicly available on registry
September 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2021
CompletedJanuary 19, 2022
September 1, 2020
8 months
September 24, 2020
January 18, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Difference in antibody titre
Difference in antibody titres at set time points during the 2020/21 influenza season in HCWs stratified by those who are vaccinated early and late
Antibody titres to be analysed at the end of the study once all samples collected - estimated May 2021
Secondary Outcomes (3)
Influenza infections
Influenza positive swabs to be analysed at the end of the study once all samples collected - estimated May 2021
Breath analysis for influenza diagnosis
Results to be analysed post influenza season - estimated May 2021
Mask sampling for influenza diagnosis
Results to be analysed post influenza season - estimated May 2021
Study Arms (3)
Early HCWs
Health Care Workers vaccinated early prior to the influenza season
Late HCWs
Health Care Workers vaccinated just prior to the influenza season
Inpatients
Inpatients recruited for evaluation of new approaches to influenza diagnosis
Interventions
All HCWs will receive the seasonal influenza vaccine but at two different time points.
Eligibility Criteria
The study population will be composed of HCWs at University Hospitals of Leicester, that are eligible for the seasonal influenza vaccine A further study population will be composed of inpatients at the University Hospitals of Leicester presenting and / or admitted with Influenza like illness
You may qualify if:
- For Health care workers (HCWs)
- Willing and able to give informed consent
- Employee at the University Hospitals of Leicester
- Willing and able to have the inactivated Influenza vaccine
- Age ≥16 For inpatients
- Inpatient at University Hospitals of Leicester
- Throat swab for influenza completed in the last 72 hours
- Willing and able to give informed consent
- Well enough to provide an exhaled breath sample without causing distress or discomfort
- Well enough to wear a face mask without causing distress or discomfort
- Age ≥16
You may not qualify if:
- Age \<16
- Unwilling and/or unable to give informed written consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Leicesterlead
- Sanofi Pasteur, a Sanofi Companycollaborator
- World Health Organizationcollaborator
- University of Warwickcollaborator
- University Hospitals, Leicestercollaborator
Study Sites (1)
Leicester Royal Infirmary
Leicester, Leicestershire, LE1 5WW, United Kingdom
Related Publications (1)
Nazareth J, Barr I, Sullivan SG, Goss C, Pan D, Martin CA, Sahota A, Stephenson I, Tang JW, Pareek M. Intra-season waning of immunity following the seasonal influenza vaccine in early and late vaccine recipients. J Infect. 2022 Dec;85(6):e172-e174. doi: 10.1016/j.jinf.2022.10.011. Epub 2022 Oct 13. No abstract available.
PMID: 36243199DERIVED
Biospecimen
With participant consent, any unused serum samples will be stored for future ethically approved research and shared with other research collaborators in other academic institutions and industry partners inside and outside of the UK for future research.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manish Pareek, PhD
University of Leicester
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2020
First Posted
September 30, 2020
Study Start
September 28, 2020
Primary Completion
May 30, 2021
Study Completion
September 1, 2021
Last Updated
January 19, 2022
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share
The participants will be identified only by initials and a participant ID number on the CRF and any electronic database. All documents will be stored securely and only accessible by study staff and authorised personnel. The study will comply with the Data Protection Act which requires data to be anonymised as soon as it is practical to do so.